Imigran

Sumatriptan, the active ingredient in Imigran, is a Triptan (5‑HT1B/1D receptor agonist) presented as a 20 mg nasal spray for nasal use. It provides acute treatment of migraine attacks in adults, relieving headache pain and associated symptoms, and is indicated for rapid relief of migraine symptoms, including throbbing head pain, nausea, and sensitivity to light, when administered at the onset of an attack.

GNH USA supplies Imigran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance and reliable logistics for global healthcare providers.

Sumatriptan is a Triptan medication used to treat migraine, a neurovascular headache disorder.

Migraine without aura: rapid relief of headache pain and associated symptoms Migraine with aura: reduction of headache severity and associated neurological symptoms Acute episodic migraine: alleviation of pain when taken at the first sign of an attack